MedPath

Air-polishing With Erythritol During Orthodontic Tretament

Not Applicable
Recruiting
Conditions
Inflammation Gum
White Spot Lesion
Interventions
Device: Ultrasonic scaler
Device: Air-Flow Prophylaxis Master
Registration Number
NCT05989750
Lead Sponsor
Catherine Giannopoulou
Brief Summary

Patients with multi-bracketed fixed orthodontic treatment are at increased risk of developing white spot lesions (WSL) and gingivitis. Various preventive strategies have been examined to prevent the development of WSLs. During initial non-surgical periodontal therapy, the use of subgingival air-polishing with erythritol powder has shown promising results in reducing deep pockets and gingival inflammation. The efficacy of its use as monotherapy in preventing WSLs and gingival inflammation in patients during orthodontic treatment, has not yet been tested.

The primary objective of the present study is to compare the effectiveness of an air-polishing device used as monotherapy versus ultrasonic instrumentation (the current gold standard procedure) in preventing white spot lesions (WSL) and gingivitis among young patients undergoing multi-bracketed fixed orthodontic treatment.

Detailed Description

This is a randomized clinical study for evaluating the performance of an air-polishing device in preventing WSLs and gingivitis among patients undergoing multi-bracketed fixed orthodontic treatment. The null hypothesis tested is that there is no difference between the air-polishing device and the conventional ultrasonic device in preventing WSLs and gingivitis during orthodontic treatment.

Clinical examination and clinical samples will be taken before, during and after orthodontic treatment. It is a single center study of 3 years duration involving samples of 60 patients attending the Division of Orthodontics for treatment. Half of the participants will be randomly assigned for treatment with the air-polishing device in every orthodontic appointment, meaning once per month, the other half will be treated with a standard ultrasonic scaler every six months. The study duration for each participant will be approximately 2 years. The investigators will then analyze the prevalence of WSLs using the Quantitative light-induced fluorescence (QLF) method. Gingivitis will be evaluated throughout the study by using standard clinical parameters; the antimicrobial efficacy against several known periodontal pathogens and the host-response (inflammatory markers in GCF) will be measured by the qPCR assay and the multiplex immunoassay, respectively. Clinical evaluation and collection of samples for microbial and host response analysis will be performed every 6 months. Incidence of bracket debonding we will be calculated and compared.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subjects about to undergo fixed orthodontic treatment will be invited to participate.
  • Age between 12 and 16 years only participants
  • Informed written consent obtained by the parents
Exclusion Criteria
  • Clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject
  • Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation
  • Previous enrolment into the current investigation
  • Enrolment of the PI, his/her family members, employees and other dependent persons
  • History of fixed orthodontic treatment
  • Defects on enamel on labial surfaces of the teeth
  • Untreated cavitated lesions
  • Plaque levels >25%
  • Periodontitis
  • Multiple missing teeth
  • Cleft lip and/or palate or other craniofacial anomalies or syndromes
  • Patients taking any regular medication
  • Patients with asthmatic problems

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control procedureUltrasonic scalerUltrasonic scaling and polishing will be performed every 6 months for subgingival cleaning
Test procedureAir-Flow Prophylaxis MasterAIR-FLOW PROPHYLAXIS MASTER with erythritol powder (AIR FLOW Powder Plus) will be used every month for 2 years for subgingival cleaning
Primary Outcome Measures
NameTimeMethod
Appearance on inflammatory lesions during orthodontic treatmnet2 years

Number of participants showing signs of inflammation based on clinical parameters during the 2-year period of orthodontic treatment.

Appearance of white spot lesions (WSL) during orthodontic movement with fixed appliances.2 years

Number of participants with white spot lesions appearence during the 2-years period of orthodontic treatment

Changes from baseline in clinical parameters2 years

plaque accumulation gingival inflammation pocket probing depth bleeding on probing gingival recessions

Secondary Outcome Measures
NameTimeMethod
Patient acceptance2 years

Visual Analogue Scale (VAS) with 0: very satisfied and 10: unsatisfied

Inflammatory markers in GCF from baseline2 years

Changes of the Inflammatory markers in the gingival crevicular fluid (GCF) throughout the study will be analyzed by the Bioplex 200 Suspension array system. The concentration of these markers will be expreseed as pg/ml

Tooth sensitivity2 years

Visual Analogue Scale (VAS) with 0: no sensitivity and 10: worst senstitivity

Total bacterial counts and counts of 6 periodontal pathogens in subgingival samples from treated pockets2 years

Changes from baseline of microorganisms will be identified and enumerated by laboratory Real-time Polymerase Chain Reaction

Toral tretament time2 years

Treatment time will be recorded at each visit

Trial Locations

Locations (1)

University of Geneva, University Clinics of Dental Medicine

🇨🇭

Geneva, Switzerland

© Copyright 2025. All Rights Reserved by MedPath